Navigation Links
Predictive Biomarker Discovery for Oncology Small-Molecules and Biologics - a Webinar Hosted by Xtalks
Date:5/9/2013

Toronto, Canada (PRWEB) May 09, 2013

Recent advances in next-generation sequencing technologies are revolutionizing the way human disease is defined, providing avenues to develop novel, individualized therapies that target the genomic underpinnings of a patient’s condition. No disease has been more directly impacted by this than cancer, which is fundamentally a disorder of acquired somatic alterations.

Dr. Jameel Shah, Principal Scientist and Group Leader of Oncology at Eurofins Panlabs will speak about the Integration of High-Content Cell Line Profiling and Univariate Genomics Analysis to Discover and Prioritize Predictive Biomarkers in Oncology. Several examples will be discussed in this webinar to illustrate the predictive power of this approach to identify biomarkers of response.

Co-speaker DR. Jonathan Crane, Senior Scientist of Oncology and Cell Biology at Eurofins Panlabs will discuss High-content Live-cell Imaging Analysis of Therapeutic Monoclonal Antibody Binding and Potency Across 240 Genomically Defined Cancer Cell Lines. This presentation will describe the high-throughput parallelization of quantitative, comparative therapeutic antibody binding measurements and drug response profiling data by new high-content imaging.

A Q&A with the audience will follow the main presentation.

For more information about this event or to register, visit:
http://www.xtalks.com/OncoPanel-cell-line-profiling-and-imaging-analysis.ashx

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Karen Lim (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10704346.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
2. Data mining opens the door to predictive neuroscience
3. Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type
4. GNS Healthcare Joins Orion Bionetworks to Develop Predictive Models for Multiple Sclerosis and Other Diseases
5. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
6. Biomarkers - Technologies, Markets and Companies
7. Use Biomarkers in Alzheimers Disease Clinical Trials, Says Expert Group
8. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
9. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
10. MarketsandMarkets: Global Biomarkers Market worth $25.79 Billion by 2016
11. Foundation of UMDNJ Receives Grand Challenges Tuberculosis Biomarkers Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):